NIH GUIDE, Volume 24, Number 21, June 9, 1995

P.T. 34


  Drugs/Drug Abuse 

  Mental Disorders 


National Institute on Drug Abuse

The National Institute on Drug Abuse (NIDA) announces the

availability of funds to supplement existing NIH-supported individual

research project grants (R01) to study issues related to marijuana,

including issues in the context of polysubstance abuse and/or

comorbid mental disorders and other diseases, e.g., HIV infection.

Research is requested in the following areas: etiology to determine

the interaction of multiple biological, genetic, social,

psychological, cultural, and environmental factors and processes

associated with the initiation and progression of marijuana use and

abuse; epidemiology to understand the factors associated with the

trends in incidence and prevalence and patterns of marijuana use

among various subpopulations including ethnic groups, rural youth,

preadolescents, school dropouts; social, psychological,

physiological, and health sequelae and consequences of marijuana use;

and, assessment of interventions to prevent the initiation and

progression of marijuana use and its consequences.  Within the area

of prevention and treatment, issues that may be addressed included

client evaluation, engagement, retention, cost/effectiveness, and

family and couples factors.  Studies using animal models as well as

human subjects both in clinical settings as well as the community are

encouraged.  Cross-cutting issues that impact marijuana use are

strongly recommended to include comparative studies across gender,

ethnic groups, and age cohorts.

For FY 1995, $250,000 will be available for administrative

supplements to existing R01 grants only.  These supplements must be

within the scope of the parent grant.  Administrative supplements

will undergo a program, grants management, and budget review within

the NIDA.  Administrative supplements may be submitted at any time

for the remainder of FY 1995, but no later than August 1, 1995; any

one award should not be more than 25 percent of the Council-approved

direct cost budget for FY 1995 or $100,000, whichever is less.

For FY 1996, it is anticipated that approximately $500,000 will be

available for both administrative and competing renewal supplements.

The competing renewal supplements will be reviewed in accordance with

NIH standard review procedures, i.e., peer review/council review.

Competing renewal supplement requests must be submitted utilizing the

following receipt dates:  March 1, July 1 and November 1.

Administrative supplements may be submitted any time during the

fiscal year, but no later than August 1, 1996.


Zili Sloboda, Ph.D.

Division of Epidemiology and Prevention Research

National Institute on Drug Abuse

5600 Fishers Lane

Rockville, MD  20857

Telephone:  (301) 443-6504



Return to 1995 Index

Return to NIH Guide Main Index

Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS) - Government Made Easy

Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.